2020
DOI: 10.1111/cod.13451
|View full text |Cite
|
Sign up to set email alerts
|

Systemic allergic dermatitis presenting as acute generalized exanthematous pustulosis due to betamethasone sodium phosphate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 11 publications
0
6
0
Order By: Relevance
“…Although rarely, SAD has been described in subjects contact sensitized to CSs and subsequently treated with these drugs via the systemic route 1,6 . Clinical features of SAD by CSs include maculopapular, eczematous, urticaria‐like eruptions, and acute generalized exanthematous pustulosis 1,7 . The intra‐articular route has been reported rarely, and in these cases triamcinolone acetonide was exceptionally the culprit CS 1,8 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although rarely, SAD has been described in subjects contact sensitized to CSs and subsequently treated with these drugs via the systemic route 1,6 . Clinical features of SAD by CSs include maculopapular, eczematous, urticaria‐like eruptions, and acute generalized exanthematous pustulosis 1,7 . The intra‐articular route has been reported rarely, and in these cases triamcinolone acetonide was exceptionally the culprit CS 1,8 .…”
Section: Discussionmentioning
confidence: 99%
“…1,6 Clinical features of SAD by CSs include maculopapular, eczematous, urticaria-like eruptions, and acute generalized exanthematous pustulosis. 1,7 The intra-articular route has been reported rarely, and in these cases triamcinolone acetonide was exceptionally the culprit CS. 1,8 To the best of our knowledge, this is the first report of SAD caused by intra-articular administration of triamcinolone acetonide presenting as SDRIFE and erythema multiforme-like eruption.…”
Section: Case Reportsmentioning
confidence: 99%
“…In the study cohort, seven deaths were recorded [75,91,104,132,151,182,221]. A summary description of the patients with a fatal outcome is included in Table 2.…”
Section: Resultsmentioning
confidence: 99%
“…Severe ADR, like AGEP, have also been described. 112 Allergy to CS can be suspected also in cases of CS-sensitive diseases that do not respond or worse following the use of CS. [109][110][111] Budesonide and CS molecules without C16-methyl substitution or halogenation, such as hydrocortisone and methylprednisolone, are the stronger sensitizers.…”
Section: Heparinsmentioning
confidence: 99%